Nov 14, 2024, 12:14
Targeted therapy advancements in NSCLC – ACS Journal Cancer
ACS Journal Cancer posted the following on X:
“Targeted therapy plays an important role for patients with early and advanced-stage NSCLC carrying specific genetic alterations. Hear from Dr. Maisam Makarem and Dr. Pasi Jänne of Dana-Farber Cancer Institute about the latest advances.”
Top Advances of the Year: Targeted Therapy for Lung Cancer
Authors: Maisam makarem, Pasi A. Jänne
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 12:14
Nov 14, 2024, 12:09
Nov 14, 2024, 11:56
Nov 14, 2024, 11:49
Nov 14, 2024, 11:46
Nov 14, 2024, 11:38
Nov 14, 2024, 11:30
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26